Trial · NCT02497937
Results by group743
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 743
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Diffusing Capacity of the Lung for DLco on Pulmonary Gas Transfer (Site: Hennepin) | Placebo | Day 7,pre exercise, n =4,3 | 0.4 | Standard Deviation 1.82 | mL/mmHg/min |
| Change From Baseline in the Diffusing Capacity of the Lung for DLco on Pulmonary Gas Transfer (Site: Hennepin) | GSK2798745 2.4 mg | Day 7,pre exercise, n =4,3 | -0.6 | Standard Deviation 1.20 | mL/mmHg/min |
| Change From Baseline in the Diffusing Capacity of the Lung for DLco on Pulmonary Gas Transfer (Site: Hennepin) | Placebo | Day 7,post exercise, n =4,3 | 1.2 | Standard Deviation 1.01 | mL/mmHg/min |
| Change From Baseline in the Diffusing Capacity of the Lung for DLco on Pulmonary Gas Transfer (Site: Hennepin) | GSK2798745 2.4 mg | Day 7,post exercise, n =4,3 | 0.4 | Standard Deviation 1.12 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DLno,Day -1,post-exercise, n =7, 7 | 2.1 | Standard Deviation 1.87 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DLno,Day -1,post-exercise, n =7, 7 | 3.5 | Standard Deviation 3.66 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DLno,Day 4, n =6, 7 | -2.3 | Standard Deviation 4.01 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DLno,Day 4, n =6, 7 | 5.0 | Standard Deviation 5.51 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DLno,Day 5,pre-infusion, n =7, 7 | -6.0 | Standard Deviation 6.50 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DLno,Day 5,pre-infusion, n =7, 7 | 2.4 | Standard Deviation 8.56 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DLno,Day 5,post-infusion, n =7, 7 | -2.7 | Standard Deviation 3.83 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DLno,Day 5,post-infusion, n =7, 7 | -3.3 | Standard Deviation 3.27 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DLno,Day 7,pre-exercise, n =7, 7 | -1.9 | Standard Deviation 6.19 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DLno,Day 7,pre-exercise, n =7, 7 | 6.0 | Standard Deviation 9.96 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DLno,Day 7, post-exercise,n =7,7 | 1.5 | Standard Deviation 5.37 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DLno,Day 7, post-exercise,n =7,7 | 8.6 | Standard Deviation 10.19 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DM,Day -1,post-exercise, n =7, 7 | 1.0 | Standard Deviation 0.85 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DM,Day -1,post-exercise, n =7, 7 | 1.7 | Standard Deviation 1.53 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | Placebo | DM,Day 4, n =6, 7 | -1.0 | Standard Deviation 1.82 | mL/mmHg/min |
| Change From Baseline in Diffusing Capacity of the Lung for Nitric Oxide (DLno) and Membrane Conductance (DM) | GSK2798745 2.4 mg | DM,Day 4, n =6, 7 | 2.4 | Standard Deviation 2.61 | mL/mmHg/min |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02497937/results?page=2